about
alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cellsTyro3, Axl, and Mertk receptor signaling in inflammatory bowel disease and colitis-associated cancerTwist mediates suppression of inflammation by type I IFNs and AxlParadoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancerTAM receptors are pleiotropic inhibitors of the innate immune responseT cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.Immunobiology of the TAM receptors.High calcium permeability and calcium block of the alpha9 nicotinic acetylcholine receptor.Effects of quinine, quinidine, and chloroquine on alpha9alpha10 nicotinic cholinergic receptors.MERTK as negative regulator of human T cell activationTargeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastomaTAM receptor signaling in immune homeostasis.Gas6/Axl pathway is activated in chronic liver disease and its targeting reduces fibrosis via hepatic stellate cell inactivation.Stromal-cell regulation of natural killer cell differentiation.AXL receptor tyrosine kinase is required for T cell priming and antiviral immunity.Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptorsTAM receptor signaling and autoimmune disease.Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells.Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.Viral Infection Sensitizes Human Fetal Membranes to Bacterial Lipopolysaccharide by MERTK Inhibition and Inflammasome Activation.Direct interaction of serotonin type 3 receptor ligands with recombinant and native alpha 9 alpha 10-containing nicotinic cholinergic receptors.Death begets a new beginning.Block of the alpha9 nicotinic receptor by ototoxic aminoglycosides.Mixed nicotinic-muscarinic properties of the alpha9 nicotinic cholinergic receptor.The PharmacologistTAM receptor function in the retinal pigment epitheliumBringing on the itch
P50
Q24629329-B894CD9E-79AE-4A96-B725-D241EB2AD851Q26823237-31FCC011-02D6-42BB-95B9-2F3CF04F441FQ28509359-B686F8A1-03DB-4E2C-AE05-4D986CCE4D60Q28588141-E0277C75-75D9-4B82-B765-472BC5265047Q28592484-FFA0FD4F-1510-4C5D-86F2-27ED6CA13C4DQ33595572-ABEEF37E-7E81-4A19-9BFB-661365064D00Q33796991-869F82B6-08A7-4BE9-872C-B3084845F547Q33893077-A7340F95-B0D8-40A1-8291-DAD5CB6BDC9AQ34426448-218A6684-4ED2-4120-91F5-D36C3F5AD6D7Q35207099-B570A5E6-1126-40CB-BD76-6187F0D966DFQ35800124-58FB3EF5-35DD-4711-A236-19A3FB719ACAQ35819380-3AA029B3-7C8E-4AAE-9A24-A2C5615E0C54Q35977791-B369E193-CFD4-4B36-8CB6-E45CD418D699Q36788022-7F7B4632-BE46-4463-B08C-77F1FC69F278Q37047246-911E55E9-2B0F-486A-B09A-DA2D69487F59Q37188519-FC4AB57E-747D-4065-9BF9-0206D403348FQ37804572-ECA4858F-3DD9-4769-BA36-E29BD1B56B5DQ40216222-7945BFD0-3654-4D71-8BD8-3D3DAAED9719Q40234467-4F3EC5E1-8337-47D8-AF25-96009EB84DEDQ41071219-95EF20B8-9C4F-4C8C-90D4-A6EC3C3EEF26Q41936403-FCECD3CB-6207-40E9-8402-2C9FF953B452Q44403729-237D842E-866A-431F-BB3F-AC9704044924Q48193714-F7E45313-CC51-4ED8-97E7-EA3CEAC80254Q50494093-8BE5BF28-C590-423E-88DD-725F12B0DDA7Q50722172-44DCA2F5-8017-48B2-AFBE-BC5E885079A9Q56878897-3BBF2C5A-0E77-45BB-810E-082ADD7CADD1Q56878898-245018A7-232F-4524-8348-324F53325C34Q83226402-7DD1D289-0922-45D8-8937-A8970FB260C9
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Carla V. Rothlin
@ast
Carla V. Rothlin
@en
Carla V. Rothlin
@es
Carla V. Rothlin
@nl
Carla V. Rothlin
@sl
type
label
Carla V. Rothlin
@ast
Carla V. Rothlin
@en
Carla V. Rothlin
@es
Carla V. Rothlin
@nl
Carla V. Rothlin
@sl
prefLabel
Carla V. Rothlin
@ast
Carla V. Rothlin
@en
Carla V. Rothlin
@es
Carla V. Rothlin
@nl
Carla V. Rothlin
@sl
P106
P1153
55929857400
6602968764
P21
P31
P496
0000-0002-5693-5572